Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay

NCT01120678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-11-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients \>3 days of age.

Conditions

  • Neonatal Sepsis

Sponsors & Collaborators

  • Wallace H. Coulter Foundation

    collaborator OTHER
  • University of Virginia

    lead OTHER

Principal Investigators

  • Karen Fairchild, MD · University of Virginia School of Medicine

Eligibility

Min Age
3 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01120678 on ClinicalTrials.gov